O. Vynnychenko, Y. Moskalenko, and R. Moskalenko, “Markers of inflammation as predictors of efficacy of trastuzumab therapy in HER2-positive metastatic breast cancer patients”, Regul. Mech. Biosyst., vol. 16, no. 1, p. e25003, Jan. 2025.